Cargando…

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Detalles Bibliográficos
Autores principales:	Hao, Zhaonian, Li, Ruyuan, Wang, Yuanyuan, Li, Shuangying, Hong, Zhenya, Han, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822719/ https://www.ncbi.nlm.nih.gov/pubmed/35130967 http://dx.doi.org/10.1186/s40364-022-00351-x

Ejemplares similares

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Macrophage, the potential key mediator in CAR-T related CRS
por: Hao, Zhaonian, et al.
Publicado: (2020)

Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
por: Shou, Dawei, et al.
Publicado: (2016)

Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer
por: Yu, Bo, et al.
Publicado: (2022)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Correction to: Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer
por: Jianyi, Ding, et al.
Publicado: (2022)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
por: Zhao, Yang, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor
por: Li, Yinan, et al.
Publicado: (2022)

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2020)

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
por: Tian, Xinyu, et al.
Publicado: (2019)

Correction: Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells
Publicado: (2023)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
por: Li, Shuangying, et al.
Publicado: (2022)

Author Correction: Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis
por: Shao, Bin, et al.
Publicado: (2023)

Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
por: Xu, Juan, et al.
Publicado: (2023)

Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review
por: Wang, Zhenhao, et al.
Publicado: (2022)

Correction: Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expression
por: Choi, You Yeon, et al.
Publicado: (2022)

Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
Publicado: (2023)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells
por: Qin, Guohui, et al.
Publicado: (2023)

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
por: Colligan, Sean H., et al.
Publicado: (2022)

Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
por: Cao, Xin-xin, et al.
Publicado: (2019)

Author Correction: Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression
por: Chong, Yuen Ping, et al.
Publicado: (2023)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022)

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
por: Zalfa, Cristina, et al.
Publicado: (2021)

Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
por: Zhang, Peitao, et al.
Publicado: (2022)

The role of myeloid-derived suppressor cells in liver cancer
por: Zhou, Shiyue, et al.
Publicado: (2023)

Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
por: Jin, Shuiling, et al.
Publicado: (2020)

Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies
por: Hussain, Khiyam, et al.
Publicado: (2021)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer
por: Wang, Yungang, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy
por: Iglesias-Escudero, María, et al.
Publicado: (2020)

Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
por: Wang, Yan, et al.
Publicado: (2022)

Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
por: Li, Yanan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22nl7a183gg97ocnmm36q8rjkl